MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1

Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer

(2019) Tong Liu et al.   Molecular Cancer

Involvement of the Dysregulation of miR-23b-3p, miR-195-5p, miR-656-5p, and miR-340-5p in Trastuzumab Resistance of HER2-Positive Breast Cancer Cells and System Biology Approach to Predict Their Targets Involved in Resistance

(2019) Zohreh Rezaei et al.   DNA AND CELL BIOLOGY

Long noncoding RNA MPRL promotes mitochondrial fission and cisplatin chemosensitivity via disruption of pre-miRNA processing

(2019) Tian Tian et al.   CLINICAL CANCER RESEARCH

MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition via TGFβ1/Smad2 signaling pathway in human bladder cancer

(2019) Xi Chao Wei et al.   OncoTargets and Therapy

MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer

(2018) Manxin Xie et al.   BIOMEDICINE & PHARMACOTHERAPY

miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling

(2018) Meng Lu et al.   DNA AND CELL BIOLOGY

miR-132 targets FOXA1 and exerts tumor-suppressing functions in thyroid cancer

(2018) Xin Chen et al.   ONCOLOGY RESEARCH

Identification of the tumour transition states occurring during EMT

(2018) Ievgenia Pastushenko et al.   NATURE

LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5

(2018) Mingbao Zhang et al.   CANCER BIOLOGY & THERAPY

TGF-β1 promotes cell migration in hepatocellular carcinoma by suppressing reelin expression

(2018) Yijiao Luo et al.   GENE

Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail

(2017) Hyuk Moon et al.   GASTROENTEROLOGY

MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma

(2017) Zhen-Xiu Cheng et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway

(2017) Lanfang Zhang et al.   MOLECULAR CARCINOGENESIS

TGF-β receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis

(2017) Salih Gencer et al.   Science Signaling

Suppression of TGF-β1 enhances chemosensitivity of cisplatin-resistant lung cancer cells through the inhibition of drug-resistant proteins

(2017) Jin Wang et al.   Artificial Cells Nanomedicine and Biotechnology

TGF-β receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis

(2017) Salih Gencer et al.   Science Signaling

MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4

(2016) Weiwei Fu et al.   PROSTATE

Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma

(2016) Xin Zhang et al.   Experimental and Therapeutic Medicine

miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells

(2015) Jian-Li Zhao et al.   IUBMB LIFE

MicroRNA-132 enhances transition from inflammation to proliferation during wound healing

(2015) Dongqing Li et al.   JOURNAL OF CLINICAL INVESTIGATION

MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1

(2014) Zhan-Guo Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

TGF-beta Signaling in Cancer Treatment

(2014) Isabel Fabregat et al.   CURRENT PHARMACEUTICAL DESIGN

Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF- 

(2014) Z. Wiener et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Histological and molecular aspects of oral squamous cell carcinoma (Review)

(2014) CÉSAR RIVERA et al.   Oncology Letters

Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer

(2013) Lu Lu et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Delivering the promise of miRNA cancer therapeutics

(2012) Diane M. Pereira et al.   DRUG DISCOVERY TODAY

miR-212/132 expression and functions: within and beyond the neuronal compartment

(2012) A. Wanet et al.   NUCLEIC ACIDS RESEARCH

DNA methylation silences miR-132 in prostate cancer

(2012) A Formosa et al.   ONCOGENE

miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor

(2011) Jong-Kook Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator

(2010) Dimitrios Lagos et al.   NATURE CELL BIOLOGY

Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy

(2009) S. Choi et al.   JOURNAL OF DENTAL RESEARCH

MicroRNAs: new regulators of immune cell development and function

(2008) David Baltimore et al.   NATURE IMMUNOLOGY

Survival following primary surgery for oral cancer

(2008) Simon N Rogers et al.   ORAL ONCOLOGY